1.
West Indian med. j
;
42(3): 121-3, Sept. 1993.
Artículo
en Inglés
| LILACS
| ID: lil-130582
RESUMEN
A randomized controlled trial of Solcoseryl, DuoDerm and conventional conservative therapy with Eusol has been performed in 32 patients with homozygous sickle-cell (SS) disease. After 12 weeks' baseline observation, patients were randomized to one of three therapies and monitored for a further 12 weeks. Of 44 ulcerated legs, 20 received control treatment, 12 Solcoseryl and 12 DuoDerm. DuoDerm was generally unacceptable, and two-thirds of the patients defaulted from this treatment. Solcoseryl increased ulcer healing compared to the controls but the difference was not significant. Solcoseryl was well tolerated and may have a role in the treatment of chronic leg ulcers of sickle-cell disease.
Asunto(s)
Humanos , Masculino , Femenino , Actiemil/uso terapéutico , Coloides/uso terapéutico , Anemia de Células Falciformes/complicaciones , Úlcera de la Pierna/tratamiento farmacológico , Apósitos Oclusivos , Ensayos Clínicos Controlados Aleatorios como Asunto , Cooperación del Paciente , Jamaica
2.
Artículo
en Inglés
| IMSEAR
| ID: sea-41300
3.
Artículo
en Inglés
| IMSEAR
| ID: sea-42465